DOMAIN Therapeutics
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
5
Funding Rounds
$98.6m
Money raised
Overview
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa**** Ne* |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa**** Ne* |
|
- | |
| Em* Fi*** | - | - | - |
| Sy**** Ry*** | - | - | - |
| Yo L. Be | - | - | - |
| Ro De Po*** | - | - | - |
| La* Ru | - | - | - |
| Ja*** Hu*** | - | - |
Funding
Funding series
Funding Series Analysis
The company DOMAIN Therapeutics has raised a total of $56.56m in funding over 5 rounds.
Key Insights:
- DOMAIN Therapeutics Series A round, May 2022: $42m
- DOMAIN Therapeutics , May 2019: $3.9m
- DOMAIN Therapeutics funding round, July 2012: $2.46m
- DOMAIN Therapeutics Series C round Funding Round 2006: $8.2m
- Domain Therapeutics 2022 Funding Round: $42m
DOMAIN Therapeutics Series A round, May 2022
$42m
DOMAIN Therapeutics , May 2019
$3.9m
DOMAIN Therapeutics funding round, July 2012
$2.46m
DOMAIN Therapeutics Series C round Funding Round 2006
$8.2m
Domain Therapeutics 2022 Funding Round
$42m
Industries
DOMAIN Therapeutics is active in the following industries: